NCT04706208

Brief Summary

Many adults with spinal cord injury (SCI) suffer from long-term debilitating neuropathic pain. Available treatments, including opioids, are ineffective at eliminating this pain. Based on preliminary data from Dr Morse and from Dr Van de Winckel, we have demonstrated that brain areas that are important for body awareness and pain perception (parietal operculum, insula) have weaker brain connectivity in adults with spinal cord injury than in able-bodied healthy adults and that Cognitive Multisensory Rehabilitation (CMR) can restore these networks. This study uses a delayed treatment arm phase I randomized controlled trial (RCT) for adults with SCI and a comparison of baseline outcomes in adults with SCI vs able-bodied healthy adults to address two aims: AIM 1: Determine baseline differences in resting-state and task-based fMRI activation and connectivity in adults with SCI compared to able-bodied healthy controls. AIM 2: Identify changes in brain activation and connectivity, as well as behavioral outcomes in pain and body awareness in adults with SCI after CMR versus standard of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 12, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

3.2 years

First QC Date

January 8, 2021

Last Update Submit

September 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Numeric Rating Scale (NPRS) - part of the International SCI Basic Pain Data Set

    The numeric pain rating scale assesses the highest, lowest and average pain ratings over the past week. The 1-10 numerical pain rating scale has been recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) consensus group for use in pain clinical trials and by the 2006 National Institute on Disability and Rehabilitation Research (NIDRR) SCI Pain outcome measures consensus group. This scale is recommended to standardize pain outcomes across studies.

    weekly during the two intervention periods (each 12 weeks)

Secondary Outcomes (11)

  • Physical Activity Recall Questionnaire

    baseline - mid evaluation (after 12 weeks) - final evaluation (after second period of 12 weeks)

  • Pittsburgh Sleep Quality Index (PSQI)

    baseline - mid evaluation (after 12 weeks) - final evaluation (after second period of 12 weeks)

  • Spielberger State-Trait Anxiety Inventory

    baseline - mid evaluation (after 12 weeks) - final evaluation (after second period of 12 weeks)

  • Patient Health Questionnaire (PHQ-9)

    baseline - mid evaluation (after 12 weeks) - final evaluation (after second period of 12 weeks)

  • Moorong Self-Efficacy Scale (MSES)

    baseline - mid evaluation (after 12 weeks) - final evaluation (after second period of 12 weeks)

  • +6 more secondary outcomes

Study Arms (3)

One time testing - able-bodied healthy adults

OTHER

Participants in this arm will be able-bodied healthy adults who will not receive an intervention. This is just a one time testing of clinical assessments (over zoom), one MRI scan, and an optional blood draw test.

Behavioral: Clinical AssessmentBehavioral: Magnetic Resonance Imaging (MRI)Other: OPTIONAL: blood draw

Usual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.

EXPERIMENTAL

This is a delayed treatment arm phase I randomized controlled trial (RCT) for participants with spinal cord injury and neuropathic pain. Participants in this arm will first receive usual care and then switch over to the experimental cognitive multisensory therapy training.

Behavioral: Cognitive Multisensory TherapyOther: Usual CareBehavioral: Clinical AssessmentBehavioral: Magnetic Resonance Imaging (MRI)Other: OPTIONAL: blood draw

Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.

EXPERIMENTAL

This is a delayed treatment arm phase I randomized controlled trial (RCT) for participants with spinal cord injury and neuropathic pain. Participants in this arm will first receive the experimental cognitive multisensory therapy training and then switch over to usual care.

Behavioral: Cognitive Multisensory TherapyOther: Usual CareBehavioral: Clinical AssessmentBehavioral: Magnetic Resonance Imaging (MRI)Other: OPTIONAL: blood draw

Interventions

Cognitive multisensory rehabilitation (CMR) is a type of physical therapy that incorporates conscious perception of body positions and movements during (multi)sensory discrimination exercises. The treating therapists will give 40 minutes of discrimination exercises embedded in functional movements followed by 5 minutes of applying the learned strategies during activities of daily living. CMR uses several types of discrimination exercises: Participants discriminated shapes, length, weight, distance, resistance, textures or compare kinesthetic information with visual information for integration of multisensory information. Solving the discrimination task is combined with reflection and a learning process, prompted by the therapist on how the limb (was) moved or was positioned.

Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.Usual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.

Standard of care treatment for neuropathic pain after spinal cord injury

Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.Usual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.

Clinical assessments are detailed below. Screening will include demographic and general health data; mini mental state evaluation (MMSE)-short version; Edinburgh handedness inventory; and the kinesthetic and visual imagery questionnaire (KVIQ).

Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.One time testing - able-bodied healthy adultsUsual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.

The MRI scanning will include structural scans, resting-state functional MRI, and 4 task-based functional MRI.

Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.One time testing - able-bodied healthy adultsUsual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.

This part is OPTIONAL: 38ml of blood will be taken one time (for able body adults) or at 3 time points (for adults with spinal cord injury and neuropathic pain.

Cognitive Multisensory Therapy, then Usual Care - adults with spinal cord injury + neuropathic pain.One time testing - able-bodied healthy adultsUsual Care, then Cognitive Multisensory Therapy - adults with spinal cord injury + neuropathic pain.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SCI participants:
  • SCI of ≥ 3months
  • medically stable with paraplegia (ASIA grade A-C, who can self-transfer with some assistance)
  • neuropathic pain (\>3 on the numeric pain rating scale)
  • Able-bodied participants:
  • sex and age matched
  • healthy, able-bodied

You may not qualify if:

  • \- MRI contra-indications (stabilizing hardware is typically MRI safe) including seizures, cognitive impairment, or other major medical complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of MInnesota (Brain Body Mind Lab, Division of Physical Therapy, Department of Rehab Med, Medical School)

Minneapolis, Minnesota, 55455, United States

Location

Related Publications (2)

  • Van de Winckel A, Carpentier S, Deng W, Bottale S, Hendrickson T, Zhang L, Wudlick R, Linnman C, Battaglino R, Morse L. Identifying Body Awareness-Related Brain Network Changes After Cognitive Multisensory Rehabilitation for Neuropathic Pain Relief in Adults With Spinal Cord Injury: Protocol of a Phase I Randomized Controlled Trial. Top Spinal Cord Inj Rehabil. 2022 Fall;28(4):33-43. doi: 10.46292/sci22-00006. Epub 2022 Nov 15.

    PMID: 36457363BACKGROUND
  • Van de Winckel A, Carpentier ST, Deng W, Bottale S, Zhang L, Hendrickson T, Linnman C, Lim KO, Mueller BA, Philippus A, Monden KR, Wudlick R, Battaglino R, Morse LR. Identifying Body Awareness-Related Brain Network Changes after Cognitive Multisensory Rehabilitation for Neuropathic Pain Relief in Adults with Spinal Cord Injury: Delayed Treatment arm Phase I Randomized Controlled Trial. medRxiv [Preprint]. 2023 Feb 10:2023.02.09.23285713. doi: 10.1101/2023.02.09.23285713.

    PMID: 36798345BACKGROUND

Related Links

MeSH Terms

Conditions

Spinal Cord InjuriesNeuralgia

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPeripheral Nervous System DiseasesNeuromuscular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Ann Van de Winckel, Van de Winckel

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2021

First Posted

January 12, 2021

Study Start

September 1, 2020

Primary Completion

November 30, 2023

Study Completion

February 29, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

The datasets (de-identified individual participant data and data dictionary) analyzed for this study can be found in the Dryad repository and will be made available upon publication of the article.

Locations